These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7864514)

  • 1. Interview with Pier-Luigi Meroni. What is going to happen tomorrow in the field of anti-endothelial cell autoantibodies related to vasculitis?
    Meroni PL
    Ann Med Interne (Paris); 1994; 145(7):467-8. PubMed ID: 7864514
    [No Abstract]   [Full Text] [Related]  

  • 2. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner.
    Carvalho D; Savage CO; Isenberg D; Pearson JD
    Arthritis Rheum; 1999 Apr; 42(4):631-40. PubMed ID: 10211876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-endothelial cell antibodies--clinical significance].
    Grunebaum E; Renaudineau E; Shoenfeld Y
    Harefuah; 1997 Nov; 133(10):458-62. PubMed ID: 9418321
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to Hsp60 in vasculitis-associated systemic autoimmune diseases.
    Jamin C; Dugué C; Alard JE; Jousse S; Saraux A; Guillevin L; Piette JC; Youinou P
    Arthritis Rheum; 2005 Dec; 52(12):4028-38. PubMed ID: 16320351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis.
    Praprotnik S; Rozman B; Blank M; Shoenfeld Y
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):660-4. PubMed ID: 11020952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model.
    Damianovich M; Gilburd B; George J; Del Papa N; Afek A; Goldberg I; Kopolovic Y; Roth D; Barkai G; Meroni PL; Shoenfeld Y
    J Immunol; 1996 Jun; 156(12):4946-51. PubMed ID: 8648146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-endothelial cell antibodies in chronic leg ulcer: prevalence and significance].
    Guillet G; Garcia C; Sassolas B; Lonceint J; Youinou P
    Ann Dermatol Venereol; 2001 Dec; 128(12):1301-4. PubMed ID: 11908131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to vascular endothelial cell antigens in systemic vasculitis.
    McMenemy A
    Am J Med; 1990 Oct; 89(4):548. PubMed ID: 2220898
    [No Abstract]   [Full Text] [Related]  

  • 9. Lytic IgG anti-endothelial cell antibodies in vasculitis.
    Baguley E; Hughes GR
    Lancet; 1988 Oct; 2(8616):907. PubMed ID: 2902350
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of the endothelium in systemic vasculitis.
    Savage CO; Cooke SP
    J Autoimmun; 1993 Apr; 6(2):237-49. PubMed ID: 8499061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interview with Graham Hughes. What is going to happen tomorrow in the field of anti-phospholipid antibodies?. Interview by P. Youinou.
    Hughes G
    Ann Med Interne (Paris); 1992; 143(6):417-8. PubMed ID: 1295396
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vasculitis in inflammatory-rheumatic diseases--current diagnosis and therapy].
    Gross WL; Schnabel A; Reinhold-Keller E
    Z Arztl Fortbild (Jena); 1994 Nov; 88(11):881-90. PubMed ID: 7839709
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies directed to sonicated human endothelial cells in patients with vasculitis.
    Rollino C; Roccatello D; Borsa S; Bellone G; Piccoli G; Emanuelli G
    Nephron; 1996; 73(2):346-7. PubMed ID: 8773382
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenetic aspects of autoantibodies to endothelial cells in systemic vasculitis.
    Frampton G; Chan D; Khouri N; Cameron JS
    Adv Exp Med Biol; 1993; 336():35-44. PubMed ID: 7507629
    [No Abstract]   [Full Text] [Related]  

  • 15. [An interview with Loïc Guillevin. What is going to happen tomorrow in the field of vasculitis?].
    Guillevin L
    Ann Med Interne (Paris); 1994; 145(8):514-6. PubMed ID: 7710176
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelium, myeloperoxidase, anti-myeloperoxidase interaction in vasculitis.
    Varagunam M; Adu D; Taylor CM; Michael J; Richards N; Neuberger J; Thompson RA
    Adv Exp Med Biol; 1993; 336():129-32. PubMed ID: 8296601
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions between leukocytes, the vascular endothelium and autoantibodies in the development of systemic vasculitis.
    Savage CO
    Ann Med Interne (Paris); 1993; 144(5):353-6. PubMed ID: 8291851
    [No Abstract]   [Full Text] [Related]  

  • 18. Endothelial injury in the initiation and progression of vascular disorders.
    Tesfamariam B; DeFelice AF
    Vascul Pharmacol; 2007 Apr; 46(4):229-37. PubMed ID: 17218160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cell biology, perivascular inflammation, and vasculitis.
    Cid MC
    Cleve Clin J Med; 2002; 69 Suppl 2():SII45-9. PubMed ID: 12086264
    [No Abstract]   [Full Text] [Related]  

  • 20. Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy.
    Salih AM; Nixon NB; Dawes PT; Mattey DL
    J Rheumatol; 1999 Mar; 26(3):551-5. PubMed ID: 10090161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.